Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check35 days agoChange DetectedThe web page has been updated to version 2.16.8, and the HHS Vulnerability Disclosure has been added.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check50 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.